SCHEMBL6068032

SCHEMBL6068032

CCNC(=O)Nc1nc2ccc([N+](=O)[O-])cc2s1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.74
DYRK1A Q13627 1/20 0.72
CXCR2 P25025 1/20 0.65
MAPT P10636 5/20 0.65
SMN1; SMN2 Q16637 4/20 0.65
POLB P06746 1/20 0.65
STAT1 P42224 1/20 0.65
ACP1 P24666 1/20 0.65
ABL1 P00519 3/20 0.63
NPC1 O15118 3/20 0.62
RAB9A P51151 3/20 0.62
MCL1 Q07820 1/20 0.61
RIPK1 Q13546 1/20 0.61
NOD2 Q9HC29 1/20 0.60
ALDH1A1 P00352 4/20 0.59
LMNA P02545 2/20 0.59
MEN1 O00255 3/20 0.59
RXFP1 Q9HBX9 1/20 0.58
HTT P42858 1/20 0.58
MMP13 P45452 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18529293 0.84 MAPT (0.63) KMT2ADYRK1ACXCR2MAPTSMN1; SMN2
SCHEMBL3924050 0.84 DYRK1A (1.00) KMT2ADYRK1ACXCR2MAPTSMN1; SMN2
SCHEMBL6295875 0.83 CXCR2 (0.79) KMT2ADYRK1ACXCR2MAPTSMN1; SMN2
SCHEMBL6068168 0.83 ABL1 (0.71) KMT2ASMN1; SMN2ABL1NPC1RAB9A
SCHEMBL11161571 0.82 KMT2A (0.73) KMT2ADYRK1ACXCR2MAPTSMN1; SMN2
SCHEMBL16732745 0.82 DYRK1A (0.78) KMT2ADYRK1ACXCR2MAPTSMN1; SMN2
SCHEMBL10599108 0.82 KMT2A (0.80) KMT2ADYRK1ACXCR2MAPTSMN1; SMN2
SCHEMBL16747337 0.81 DYRK1A (0.77) KMT2ADYRK1ACXCR2MAPTSMN1; SMN2
SCHEMBL27093075 0.81 CXCR2 (0.72) KMT2ADYRK1ACXCR2MAPTSMN1; SMN2
SCHEMBL27566837 0.81 DYRK1A (0.76) KMT2ADYRK1ACXCR2MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091227-B2 Benzothiazole derivatives ABBOTT GMBH & CO. KG (DE) 2006-08-15 US disclosed
US-20030153568-A1 Benzothiazole derivatives BASF AKTIENGESELLSCHAFT LUDWIGSHAFEN, GERMANY 2003-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153568-A1 Benzothiazole derivatives TK1, FLT1, CDK1 KMT2A 2137/4885DYRK1A 231/4885CXCR2 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.